Carbamic Acid

Carbamic Acid

SCHEMBL15512914

Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cc(C3CC3)nc21.NC(=O)O

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 14/20 0.68
FLT3 P36888 11/20 0.68
KIT P10721 10/20 0.68
FLT1 P17948 8/20 0.68
CSF1R P07333 7/20 0.68
FLT4 P35916 5/20 0.68
LCK P06239 4/20 0.68
LYN P07948 4/20 0.68
SRC P12931 4/20 0.68
BLK P51451 4/20 0.68
FYN P06241 4/20 0.68
ABL1 P00519 3/20 0.68
JAK2 O60674 3/20 0.61
NTRK1 P04629 3/20 0.61
EPHA2 P29317 3/20 0.61
MAP4K2 Q12851 3/20 0.61
NTRK2 Q16620 3/20 0.61
TAOK1 Q7L7X3 3/20 0.61
AURKB Q96GD4 3/20 0.61
HIPK2 Q9H2X6 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL15513275 0.98 KDR (0.68) KDRFLT3KITFLT1CSF1R
SCHEMBL2821104 0.98 KDR (0.70) KDRFLT3KITFLT1CSF1R
SCHEMBL15512726 0.96 KDR (0.65) KDRFLT3KITFLT1CSF1R
SCHEMBL15512422 0.96 KDR (0.65) KDRFLT3KITFLT1CSF1R
Dimethylcarbate SCHEMBL15512477 0.95 KDR (0.64) KDRFLT3KITFLT1CSF1R
SCHEMBL2816848 0.95 KDR (0.68) KDRFLT3KITFLT1CSF1R
SCHEMBL2817427 0.94 KDR (0.67) KDRFLT3KITFLT1CSF1R
SCHEMBL15512783 0.94 KIT (0.63) KDRFLT3KITFLT1CSF1R
SCHEMBL15512555 0.94 KDR (0.63) KDRFLT3KITFLT1CSF1R
SCHEMBL15512441 0.93 KIT (0.62) KDRFLT3KITFLT1CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032572-B1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them BAYER IP GMBH (DE) 2014-03-12 EP claimed